APA

Setchell K. D. R., Clerici C., Lephart E. D., Cole S. J., Heenan C., Castellani D., Wolfe B. E., Nechemias-Zimmer L., Brown N. M., Lund T. D., Handa R. J. & Heubi J. E. (20050628). S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. : The American journal of clinical nutrition.

Chicago

Setchell Kenneth D R, Clerici Carlo, Lephart Edwin D, Cole Sidney J, Heenan Claire, Castellani Danilo, Wolfe Brian E, Nechemias-Zimmer Linda, Brown Nadine M, Lund Trent D, Handa Robert J and Heubi James E. 20050628. S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. : The American journal of clinical nutrition.

Harvard

Setchell K. D. R., Clerici C., Lephart E. D., Cole S. J., Heenan C., Castellani D., Wolfe B. E., Nechemias-Zimmer L., Brown N. M., Lund T. D., Handa R. J. and Heubi J. E. (20050628). S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. : The American journal of clinical nutrition.

MLA

Setchell Kenneth D R, Clerici Carlo, Lephart Edwin D, Cole Sidney J, Heenan Claire, Castellani Danilo, Wolfe Brian E, Nechemias-Zimmer Linda, Brown Nadine M, Lund Trent D, Handa Robert J and Heubi James E. S-equol, a potent ligand for estrogen receptor beta, is the exclusive enantiomeric form of the soy isoflavone metabolite produced by human intestinal bacterial flora. : The American journal of clinical nutrition. 20050628.